337 related articles for article (PubMed ID: 34664843)
21. [The predictive accuracy of fine needle aspiration and BRAF V600E mutation in diagnosis of papillary thyroid carcinoma].
Yu X; Wang Y; Xie QP; Yan HC; Zhao QZ; Zhang ML; Xiang C; Wang P
Zhonghua Wai Ke Za Zhi; 2019 Apr; 57(4):305-308. PubMed ID: 30929378
[No Abstract] [Full Text] [Related]
22. What to do with thyroid nodules showing benign cytology and BRAF(V600E) mutation? A study based on clinical and radiologic features using a highly sensitive analytic method.
Kim SY; Kim EK; Kwak JY; Moon HJ; Yoon JH
Surgery; 2015 Feb; 157(2):354-61. PubMed ID: 25616949
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the Clinical Validity of Droplet Digital PCR to ARMS-PCR for BRAF V600E Mutation Detection in Thyroid Nodules.
Li X; Du H; Luo J; Ding W; Lai B; He J; Xu S; Zhang Y
J Clin Lab Anal; 2020 Nov; 34(11):e23458. PubMed ID: 32671901
[TBL] [Abstract][Full Text] [Related]
24. The BRAF(V600E) mutation is associated with malignant ultrasonographic features in thyroid nodules.
Lee EJ; Song KH; Kim DL; Jang YM; Hwang TS; Kim SK
Clin Endocrinol (Oxf); 2011 Dec; 75(6):844-50. PubMed ID: 21707687
[TBL] [Abstract][Full Text] [Related]
25. Testing for BRAF (V600E) Mutation in Thyroid Nodules with Fine-Needle Aspiration (FNA) Read as Suspicious for Malignancy (Bethesda V, Thy4, TIR4): a Systematic Review and Meta-analysis.
Trimboli P; Scappaticcio L; Treglia G; Guidobaldi L; Bongiovanni M; Giovanella L
Endocr Pathol; 2020 Mar; 31(1):57-66. PubMed ID: 31811566
[TBL] [Abstract][Full Text] [Related]
26. Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules.
Beiša A; Kvietkauskas M; Beiša V; Stoškus M; Ostanevičiūtė E; Jasiūnas E; Griškevičius L; Šeinin D; Šileikytė A; Strupas K
Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):247-254. PubMed ID: 29566402
[TBL] [Abstract][Full Text] [Related]
27. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of thyroid imaging reporting and data system combined with BRAF
Wu L; Shu H; Chen W; Gao Y; Yuan Y; Li X; Lu W; Ye X; Deng H
Sci Rep; 2022 Apr; 12(1):5934. PubMed ID: 35395862
[TBL] [Abstract][Full Text] [Related]
29. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
Chung KW; Yang SK; Lee GK; Kim EY; Kwon S; Lee SH; Park DJ; Lee HS; Cho BY; Lee ES; Kim SW
Clin Endocrinol (Oxf); 2006 Nov; 65(5):660-6. PubMed ID: 17054470
[TBL] [Abstract][Full Text] [Related]
30. Predicting malignancy in thyroid nodules with benign cytology results: The role of Conventional Ultrasound, Shear Wave Elastography and BRAF V600E.
Zhang Y; Lu F; Shi H; Guo LH; Wei Q; Xu HX; Zhang YF
Clin Hemorheol Microcirc; 2022; 81(1):33-45. PubMed ID: 34958011
[TBL] [Abstract][Full Text] [Related]
31. A Combination of BRAF and EZH1/SPOP/ZNF148 Three-Gene Mutational Classifier Improves Benign Call Rate in Indeterminate Thyroid Nodules.
Xu S; Cai G; Zhu Y; Gu X; Wu J; Cheng X; Bao J; Yu H; Zhang L
Endocr Pathol; 2023 Sep; 34(3):323-332. PubMed ID: 37572175
[TBL] [Abstract][Full Text] [Related]
32. High BRAFV600E mutation frequency in Chinese patients with papillary thyroid carcinoma increases diagnostic efficacy in cytologically indeterminate thyroid nodules.
Li XJ; Mao XD; Chen GF; Wang QF; Chu XQ; Hu X; Ding WB; Zeng Z; Wang JH; Xu SH; Liu C
Medicine (Baltimore); 2019 Jul; 98(28):e16343. PubMed ID: 31305422
[TBL] [Abstract][Full Text] [Related]
33. Increased diagnostic sensitivity of palpation-guided thyroid nodule fine-needle aspiration cytology by BRAF V600E-mutation analysis.
Gimm O; Ivansson K; Beka E; Rossitti HM; Garvin S; Söderkvist P
J Pathol Clin Res; 2021 Nov; 7(6):556-564. PubMed ID: 34156770
[TBL] [Abstract][Full Text] [Related]
34. Prospective Study of Bethesda Categories III and IV Thyroid Nodules: Outcomes and Predictive Value of BRAF
Chirayath SR; Pavithran PV; Abraham N; Nair V; Bhavani N; Kumar H; Menon UV; Menon AS
Indian J Endocrinol Metab; 2019; 23(3):278-281. PubMed ID: 31641627
[TBL] [Abstract][Full Text] [Related]
35. Initial clinical experience with BRAF(V600E) mutation analysis of core-needle biopsy specimens from thyroid nodules.
Choi SH; Baek JH; Lee JH; Choi YJ; Ha EJ; Song DE; Kim JK; Chung KW; Kim TY; Kim WB; Shong YK
Clin Endocrinol (Oxf); 2016 Apr; 84(4):607-13. PubMed ID: 26215382
[TBL] [Abstract][Full Text] [Related]
36. BRAF
Zhao CK; Zheng JY; Sun LP; Xu RY; Wei Q; Xu HX
Cancer Med; 2019 Sep; 8(12):5577-5589. PubMed ID: 31397092
[TBL] [Abstract][Full Text] [Related]
37. Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens.
Smith GD; Zhou L; Rowe LR; Jarboe EA; Collins BT; Bentz JS; Wittwer CT; Chadwick BE
Acta Cytol; 2011; 55(6):576-83. PubMed ID: 22156469
[TBL] [Abstract][Full Text] [Related]
38. High-accuracy Detection of Preoperative Thyroid Nodules Using Combination of BRAF
Zhang Y; Zhang Z; Ma J; Pu J; Hou P; Yang Q
Arch Med Res; 2018 Aug; 49(6):365-372. PubMed ID: 30518486
[TBL] [Abstract][Full Text] [Related]
39. Application of the Bethesda system for reporting thyroid cytopathology for classification of thyroid nodules: A clinical and cytopathological characteristics in Bhutanese population.
Choden S; Wangmo C; Maharjan S
Diagn Cytopathol; 2021 Nov; 49(11):1179-1187. PubMed ID: 34320270
[TBL] [Abstract][Full Text] [Related]
40. Is follow-up BRAF(V600E) mutation analysis helpful in the differential diagnosis of thyroid nodules with negative results on initial analysis?
Yoon JH; Kim EK; Moon HJ; Kwak JY
PLoS One; 2013; 8(3):e58592. PubMed ID: 23505540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
